Strategy | Finance Blog
Technology Private Placement and M&A Transactions Review Week Ending May 4, 2025
Strategy | Financing | Macro & Markets Private Placement / Financing Transactions Display.: The company raised $3.4 billion of venture funding from undisclosed investors on April 28, 2025. The company is a developer of a social platform designed to help creators...
Consumer Private Placement and M&A Transactions Review Week Ending May 4, 2025
Strategy | Financing | Macro & Markets Private Placement / Financing Transactions Gorgie: The company raised $24.5 million of Series A venture funding in a deal led by Notable Capital on April 29, 2025, putting the company's pre-money valuation at $80 million....
Healthcare Private Placement and M&A Transactions Review Week Ending May 4, 2025
Strategy | Financing | Macro & Markets Private Placement / Financing Transactions Pathos: The company raised $283 million of venture funding from undisclosed investors on May 1, 2025. The company is a developer of a drug discovery platform intended to reduce the...
Technology Private Placement and M&A Transactions Review Week Ending April 27, 2025
Strategy | Financing | Macro & Markets Private Placement / Financing Transactions Monarrch: The company raised $260 million of venture funding from undisclosed investors on April 25, 2025. The company, based in Nashville, Tennessee, and Melbourne, Australia,...
Consumer Private Placement and M&A Transactions Review Week Ending April 27, 2025
Strategy | Financing | Macro & Markets Private Placement / Financing Transactions Tosi: The company raised $25.9 million of Series B venture funding in a deal led by Cambridge Companies SPG on April 24, 2025. The company is a producer of protein bars, snacks, and...
Healthcare Private Placement and M&A Transactions Review Week Ending April 27, 2025
Strategy | Financing | Macro & Markets Private Placement / Financing Transactions SHINE Technologies: The company received $122.5 million of development capital from undisclosed investors on April 21, 2025. The company is a developer of medical isotopes designed...
Technology Private Placement and M&A Transactions Review Week Ending April 20, 2025
Strategy | Financing | Macro & Markets Private Placement / Financing Transactions Auradine: The company raised $153 million of Series C venture funding in a deal led by StepStone Group on April 16, 2025. Samsung Catalyst Fund, Qualcomm Ventures, MARA holdings,...
Consumer Private Placement and M&A Transactions Review Week Ending April 20, 2025
Strategy | Financing | Macro & Markets Private Placement / Financing Transactions The Ryl Co.: The company raised $15 million of Series B venture funding from Cam Fordham, Alex Dermer and Ben Hiott on April 14, 2025. Austin Neal, Seth England and other undisclosed...
Healthcare Private Placement and M&A Transactions Review Week Ending April 20, 2025
Strategy | Financing | Macro & Markets Private Placement / Financing Transactions Glycomine: The company raised $115 million of Series C venture funding in a deal led by Advent Life Sciences and CTI Life Sciences Fund on April 16, 2025. Chiesi Ventures, Novo...
Technology Private Placement and M&A Transactions Review Week Ending April 13, 2025
Strategy | Financing | Macro & Markets Private Placement / Financing Transactions Safe Superintelligence: The company raised $2 billion of venture funding in a deal led by Greenoaks Capital Partners on April 13, 2025, putting the company's pre-money valuation at...